Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion

被引:0
作者
Y Tao
J Hou
Y-R Jiang
X-X Li
J B Jonas
机构
[1] People's Hospital,Department of Ophthalmology
[2] Peking University,Department of Ophthalmology
[3] Medical Faculty Mannheim of the Ruprecht-Karls-University,undefined
来源
Eye | 2010年 / 24卷
关键词
bevacizumab; central retinal vein occlusion; triamcinolone acetonide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:810 / 815
页数:5
相关论文
共 145 条
[1]  
Mitchell P(1996)Prevalence and associations of retinal vein occlusions in Australia. The blue mountains eye study Arch Ophthalmol 114 1243-1247
[2]  
Smith W(2000)The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study Ophthalmologica 98 113-143
[3]  
Chang A(2007)Retinal vein occlusion Chinese subjects Ophthalmology 114 1795-1796
[4]  
Klein R(1983)Classification of central retinal vein occlusion Ophthalmology 90 458-474
[5]  
Klein BE(1997)Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 486-491
[6]  
Moss SE(2005)Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases Acta Ophthalmol 83 645-663
[7]  
Meuer SM(2002)Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion Graef Arch Clin Exp Ophthalmol 240 782-783
[8]  
Liu W(2004)Visual acuity measurements J Cataract Refract Surg 30 287-290
[9]  
Xu L(2002)Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion Br J Ophthalmol 86 247-248
[10]  
Jonas JB(2004)Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion Arch Ophthalmol 122 1131-1136